Here are the members of the working group for the internationalization of industries in the biotechnology sector in Italy established by the Minister of Foreign Affairs. It follows the Italy-USA bilateral meeting that took place last November.
The members of the working group established by the Minister of Foreign Affairs and International Cooperation, Antonio Tajani, and initiated at the beginning of January have been appointed. This follows up on the biotechnology conference in the USA-Italy bilateral relationship that took place in November 2023. This was communicated through social media by the moderator Pierluigi Paracchi, CEO and co-founder of Genenta Science and a member of the executive committee of Federchimica-Assobiotec.
Internationalizing Italian Biotech
“With more than 800 companies, 14,000 employees, over 13 billion in revenue, and a strong component of Research and Development, the Italian biotechnology sector is experiencing a significant development phase and represents an important driving force for growth in sectors with increasingly high added value,” the minister stated.
The group, tasked with formulating strategies and recommendations regarding the internationalization of actors active in the field of biotechnology to strengthen the entire national sector, “reflects the attention that the Government, through the Ministry of Foreign Affairs, attributes to the international development of innovative sectors and emerging technologies, within the framework of Diplomacy for Growth,” Tajani further stated.
Representatives from industry, politics, and science at the table
Here are the members of the biotech group, in addition to Paracchi as the moderator:
Coordinators:
- Minister Plenipotentiary Mauro Battocchi, Director-General for the Promotion of the Country System & Cons. Amb. Massimo Carnelos, Head of Technological Innovation and Start-up Office, Ministry of Foreign Affairs and International Cooperation.
Members:
- Prof. Sergio Abrignani, Professor of Immunology and Immunopathology at the University of Milan and Scientific Director of the National Institute of Molecular Genetics (INGM) in Milan.
- Giovanni Caforio, Executive Chairman of Bristol Meyers Squibb
- Prof. Fabio Fava, Professor of Industrial and Environmental Biotechnology at the University of Bologna and President of the Coordination Table of the Bioeconomy of the Prime Minister’s Office (representative of the Ministry of University and Research)
- Maurizio Forte, Central Director for Export Sectors, ITA-Agency
- Giuseppe Gigli, Director of the CNR-Nanotec Nanotechnology Institute
- Anna Lambiase, President of CDP Venture Capital SGR and CEO of IR TOP Consulting
- Maria Cristina Porta, General Director of the Enea Tech and Biomedical Foundation
- Pierluigi Petrone, Vice President of Farmaindustria and CEO of Petrone Group